Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Diazoxide Attenuates Autoimmune Encephalomyelitis and Modulates Lymphocyte Proliferation and Dendritic Cell Functionality.
Both positive and negative effects on immune responses by expression of a second class II MHC molecule.
The effect of the physiological rest position of the mandible on cerebral blood flow and physical balance: an observational study.
Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up study.
A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort.
Review of laquinimod and its therapeutic potential in multiple sclerosis.
Characteristics of flow through the internal jugular veins at cervical C2/C3 and C5/C6 levels for multiple sclerosis patients using MR phase contrast imaging.
Novel Targets in Multiple Sclerosis: to Oxidative Stress and Beyond.
Cerebrospinal fluid proteomics in multiple sclerosis.
Placebo and nocebo effects in the neurological practice.
Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome.
Neuromyelitis optica spectrum disorders with multiple brainstem manifestations: a case report.
Network collapse and cognitive impairment in multiple sclerosis.
Long-term results from a phase 2 extension study of fingolimod at high and approved dose in relapsing multiple sclerosis.
Prophylactic Effect of BIO-1211 Small-Molecule Antagonist of VLA-4 in the EAE Mouse Model of Multiple Sclerosis.
Targeting Central Nervous System B Cells in Progression of Multiple Sclerosis: Is Intrathecal Anti-CD20 a Therapeutic Option?
Association study of four polymorphisms in the interleukin-7 receptor alpha gene with multiple sclerosis in Eastern Iran.
Demyelination preceding a diagnosis of central nervous system lymphoma.
Optimizing treatment success in multiple sclerosis.
Association of Epstein-Barr virus infection with multiple sclerosis in India.
Iron accumulation in multiple sclerosis: an early pathogenic event.
Impact of a 5-day expedition to machu picchu on persons with multiple sclerosis.
Toxic hepatitis after concomitant interferon beta and aloe vera treatment in a patient with multiple sclerosis: A case report.
Sphingosine-1-phosphate receptor inhibition prevents denervation-induced dendritic atrophy.
Analytical performances of SPAPLUS® turbidimeter for the quantification of albumin and IgG in serum and cerebrospinal fluid.
Pages
« first
‹ previous
…
464
465
466
467
468
469
470
471
472
…
next ›
last »